Accelerated development of vaccine benefit-risk collaboration in Europe
Project factsheets
The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.
Displaying 5 projects/programmes
Driving re-investment in R&D and responsible antibiotic use
Patient Preferences in benefit risk assessments during the drug life cycle
Pharmacoepidemiological research on outcomes of therapeutics by a European consortium
WEB-RADR 2